Merck held talks to buy Swiss biotech MoonLake for more than $3bn

All NewsJune 2, 2025

US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent